Source:http://linkedlifedata.com/resource/pubmed/id/12466145
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2003-2-10
|
pubmed:abstractText |
In autoimmune hepatitis, strong TGF-beta1 expression is found in the inflamed liver. TGF-beta overexpression may be part of a regulatory immune response attempting to suppress autoreactive T cells. To test this hypothesis, we determined whether impairment of TGF-beta signaling in T cells leads to increased susceptibility to experimental autoimmune hepatitis (EAH). Transgenic mice of strain FVB/N were generated expressing a dominant-negative TGF-beta type II receptor in T cells under the control of the human CD2 promoter/locus control region. On induction of EAH, transgenic mice showed markedly increased portal and periportal leukocytic infiltrations with hepatocellular necroses compared with wild-type mice (median histological score = 1.8 +/- 0.26 vs. 0.75 +/- 0.09 in wild-type mice; P < 0.01). Increased IFN-gamma production (118 vs. 45 ng/ml) and less IL-4 production (341 vs. 1,256 pg/ml) by mononuclear cells isolated from transgenic livers was seen. Impairment of TGF-beta signaling in T cells therefore leads to increased susceptibility to EAH in mice. This suggests an important role for TGF-beta in immune homeostasis in the liver and may teleologically explain TGF-beta upregulation in response to T cell-mediated liver injury.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0193-1857
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
284
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
G525-35
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12466145-Animals,
pubmed-meshheading:12466145-B-Lymphocytes,
pubmed-meshheading:12466145-Blotting, Northern,
pubmed-meshheading:12466145-Cells, Cultured,
pubmed-meshheading:12466145-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:12466145-Hepatitis, Autoimmune,
pubmed-meshheading:12466145-Homeostasis,
pubmed-meshheading:12466145-Immunohistochemistry,
pubmed-meshheading:12466145-Mice,
pubmed-meshheading:12466145-Mice, Transgenic,
pubmed-meshheading:12466145-Neutrophil Infiltration,
pubmed-meshheading:12466145-Phenotype,
pubmed-meshheading:12466145-Signal Transduction,
pubmed-meshheading:12466145-T-Lymphocytes,
pubmed-meshheading:12466145-Transforming Growth Factor beta
|
pubmed:year |
2003
|
pubmed:articleTitle |
Impairment of TGF-beta signaling in T cells increases susceptibility to experimental autoimmune hepatitis in mice.
|
pubmed:affiliation |
First Department of Medicine, Johannes Gutenberg-University, 55101 Mainz, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|